// App-Quantinova.ai

: Disease control and treatment pathways of asthma patients after initiating ICS/LABA

Researchers

Presenter

  • Roland Buhl

Principal Investigators

  • Liam G Heaney

  • Emil Loefroth

  • Paul Michael Larbig

  • Konstantinos Kostikas

  • Valentino Conti

  • Hui Cao

Medical Centers

  • Pulmonary Department, Mainz University Hospital, Mainz, Germany

  • Centre for Experimental Medicine, School of Medicine, Dentistry & Biomedical Science, Queens University Belfast, Northern Ireland, UK

  • Novartis Sverige AB, Kista, Sweden

  • Novartis AG, Basel, Switzerland

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

Locations

  • Germany

  • United Kingdom

  • Sweden

  • Switzerland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Cartilage oligomeric matrix protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved